CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
ItalianoMONTI, BARBARA
Dettaglio
MONTI, BARBARA
DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE
Docenti di ruolo di IIa fascia
Pubblicazioni
Risultati 1 - 20 di 56 (tempo di esecuzione: 0.001 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
|---|---|---|---|---|---|---|---|
| 1 | 3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease | Prati, Federica; De Simone, Angela; Armirotti, Andrea; Summa, Maria; Pizzirani, Daniela; Scarpell...i, Rita; Bertozzi, Sine Mandrup; Perez, Daniel I.; Andrisano, Vincenza; Perez-Castillo, Ana; Monti, Barbara; Massenzio, Francesca; Polito, Letizia; Racchi, Marco; Sabatino, Piera; Bottegoni, Giovanni; Martinez, Ana; Cavalli, Andrea; Bolognesi, Maria L. | 2015 | ACS CHEMICAL NEUROSCIENCE | 1.01 Articolo in rivista | - | |
| 2 | Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death. | Monti B; Polazzi E; Batti L; Crochemore C; Virgili M; Contestabile A. | 2007 | JOURNAL OF NEUROCHEMISTRY | 1.01 Articolo in rivista | - | |
| 3 | Alterations of markers related to synaptic function in aging rat brain, in normal conditions or under conditions of long-term dietary manipulation | MONTI B.; VIRGILI M.; CONTESTABILE A. | 2004 | NEUROCHEMISTRY INTERNATIONAL | 1.01 Articolo in rivista | - | |
| 4 | Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection | Monti B.; Polazzi E.; Contestabile A. | 2009 | CURRENT MOLECULAR PHARMACOLOGY | 1.01 Articolo in rivista | - | |
| 5 | Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation. | Peña-Altamira, E; Prati, F; Massenzio, F; Virgili, M; Contestabile, A; Bolognesi, Ml; Monti, B. | 2016 | EXPERT OPINION ON THERAPEUTIC TARGETS | 1.01 Articolo in rivista | - | |
| 6 | Characterization of DNA methylation as a function of biological complexity via dinucleotide inter-distances | Paci, G; Cristadoro, G; Monti, B; Lenci, M; Degli Esposti, M; Castellani, Gc; Remondini, D | 2016 | PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES A: MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES | 1.01 Articolo in rivista | - | |
| 7 | Chronic dietary administration of valproic acid protects neurons of the rat nucleus basalis magnocellularis from ibotenic acid neurotoxicity | Eleuteri S.; Monti B.; Brignani S.; Contestabile A. | 2009 | NEUROTOXICITY RESEARCH | 1.01 Articolo in rivista | - | |
| 8 | Chronic valproic acid administration impairs contextual memory and dysregulates hippocampal GSK-3β in rats. | Sintoni S; Kurtys E; Scandaglia M; Contestabile A; Monti B. | 2013 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 1.01 Articolo in rivista | - | |
| 9 | Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity. | Polazzi E.; Mengoni I.; Caprini M.; Peña-Altamira E.; Kurtys E.; Monti B. | 2013 | NEUROSIGNALS | 1.01 Articolo in rivista | - | |
| 10 | Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) | De Simone A.; La Pietra V.; Betari N.; Petragnani N.; Conte M.; Daniele S.; Pietrobono D.; Martin...i C.; Petralla S.; Casadei R.; Davani L.; Frabetti F.; Russomanno P.; Novellino E.; Montanari S.; Tumiatti V.; Ballerini P.; Sarno F.; Nebbioso A.; Altucci L.; Monti B.; Andrisano V.; Milelli A. | 2019 | ACS MEDICINAL CHEMISTRY LETTERS | 1.01 Articolo in rivista | - | |
| 11 | CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients | Drago, Antonio; Monti, Barbara; De Ronchi, Diana; Serretti, Alessandro | 2015 | PSYCHIATRY INVESTIGATION | 1.01 Articolo in rivista | - | |
| 12 | Deficiency of Mitochondrial Aspartate-Glutamate Carrier 1 Leads to Oligodendrocyte Precursor Cell Proliferation Defects Both In Vitro and In Vivo | Petralla S.; Pena-Altamira L.E.; Poeta E.; Massenzio F.; Virgili M.; Barile S.N.; Sbano L.; Profi...lo E.; Corricelli M.; Danese A.; Giorgi C.; Ostan R.; Capri M.; Pinton P.; Palmieri F.; Lasorsa F.M.; Monti B. | 2019 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 1.01 Articolo in rivista | ||
| 13 | Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment | Montanari S.; Mahmoud A.M.; Pruccoli L.; Rabbito A.; Naldi M.; Petralla S.; Moraleda I.; Bartolin...i M.; Monti B.; Iriepa I.; Belluti F.; Gobbi S.; Di Marzo V.; Bisi A.; Tarozzi A.; Ligresti A.; Rampa A. | 2019 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 1.01 Articolo in rivista | - | |
| 14 | Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. | De Simone A, La Pietra V, Betari N, Petragnani N, Conte M, Daniele S, Pietrobono D, Martini C, Pe...tralla S, Casadei R, Davani L, Frabetti F, Russomanno P, Novellino E, Montanari S, Tumiatti V, Ballerini P, Sarno F, Nebbioso A, Altucci L, Monti B, Andrisano V, Milelli A. | 2019 | ACS MEDICINAL CHEMISTRY LETTERS | 1.01 Articolo in rivista | - | |
| 15 | Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice | CROCHEMORE C.; PENA-ALTAMIRA E.; VIRGILI M.; MONTI B.; CONTESTABILE A. | 2005 | NEUROCHEMISTRY INTERNATIONAL | 1.01 Articolo in rivista | - | |
| 16 | Down-regulation of the mitochondrial aspartate-glutamate carrier isoform 1 AGC1 inhibits proliferation and N-acetylaspartate synthesis in Neuro2A cells. | Profilo, E; Peña-Altamira, Le; Corricelli, M; Castegna, A; Danese, A; Agrimi, G; Petralla, S; Gia...nnuzzi, G; Porcelli, V; Sbano, L; Viscomi, C; Massenzio, F; Palmieri, Em; Giorgi, C; Fiermonte, G; Virgili, M; Palmieri, L; Zeviani, M; Pinton, P; Monti, B; Palmieri, F; Lasorsa, Fm. | 2017 | BIOCHIMICA ET BIOPHYSICA ACTA | 1.01 Articolo in rivista | - | |
| 17 | Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo | Scheiner M.; Dolles D.; Gunesch S.; Hoffmann M.; Nabissi M.; Marinelli O.; Naldi M.; Bartolini M....; Petralla S.; Poeta E.; Monti B.; Falkeis C.; Vieth M.; Hubner H.; Gmeiner P.; Maitra R.; Maurice T.; Decker M. | 2019 | JOURNAL OF MEDICINAL CHEMISTRY | 1.01 Articolo in rivista | - | |
| 18 | Dysregulation of memory-related proteins in the hippocampus of aged rats and their relation with cognitive impairment. | Monti B.; Berteotti C.; Contestabile A. | 2005 | HIPPOCAMPUS | 1.01 Articolo in rivista | - | |
| 19 | Epigenetic mechanisms underlying opiate dependence. | Concas A.; Sassoè-Pognetto M.; Monti B. | 2012 | 8.04 Coordinamento di progetti di ricerca | - | ||
| 20 | Evidence for purine nucleoside phosphorylase (PNP) release from RAT C6 glioma cells. | Giuliani, P; Zuccarini, M; Buccella, S; Peña-Altamira, Le; Polazzi, E; Virgili, M; Monti, B; Poli..., A; Rathbone, Mp; Di Iorio, P; Ciccarelli, R; Caciagli, F. | 2017 | JOURNAL OF NEUROCHEMISTRY | 1.01 Articolo in rivista | - |
Copyright © 2021